Coronavirus Disease 2019 (COVID-19)
Updated: Apr 06, 2023 Overview Practice Essentials Coronavirus disease 2019 (COVID-19) is defined as illness caused by a novel...
Ritonavir-Boosted Nirmatrelvir (Paxlovid)
Nirmatrelvir is an orally bioavailable protease inhibitor that is active against MPRO, a viral protease that plays an essential role in...
Remdesivir
Remdesivir is a nucleotide prodrug of an adenosine analog. It binds to the viral RNA-dependent RNA polymerase and inhibits viral...
Smoke inhalation Injury
Practice Essentials Smoke inhalation is the leading cause of death due to fires. It produces injury through several mechanisms, including...
Ritonavir-Boosted Nirmatrelvir (Paxlovid)
Nirmatrelvir is an orally bioavailable protease inhibitor that is active against MPRO, a viral protease that plays an essential role in...
CBRNE - Chemical Warfare Mass Casualty Management
Specific Procedures for a Chemical Weapon Response Introduction This article is for managers who prepare hospital operational plans, for...
Drug Treatment for COVID-19: A Quick Summary for PCPs
Information about COVID has evolved so quickly that it can be difficult for clinicians to feel confident that they are staying current....
Critical Care Considerations in Trauma
Overview Trauma has been dubbed the forgotten epidemic and the neglected disease of modern society. Trauma annually impacts hundreds of...
Acute Myocardial Infarction
Practice Essentials Myocardial infarction (MI) (ie, heart attack) is the irreversible death (necrosis) of heart muscle secondary to...
Coronavirus Disease 2019 Treatment and Guidelines
Treatment & Management Approach Considerations Utilization of programs established by the FDA to allow clinicians to gain access to...
